These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 9560261)
1. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Whang YE; Wu X; Suzuki H; Reiter RE; Tran C; Vessella RL; Said JW; Isaacs WB; Sawyers CL Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5246-50. PubMed ID: 9560261 [TBL] [Abstract][Full Text] [Related]
2. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392 [TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766 [TBL] [Abstract][Full Text] [Related]
4. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate. Dong JT; Sipe TW; Hyytinen ER; Li CL; Heise C; McClintock DE; Grant CD; Chung LW; Frierson HF Oncogene; 1998 Oct; 17(15):1979-82. PubMed ID: 9788441 [TBL] [Abstract][Full Text] [Related]
6. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738 [TBL] [Abstract][Full Text] [Related]
7. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947 [TBL] [Abstract][Full Text] [Related]
8. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Vlietstra RJ; van Alewijk DC; Hermans KG; van Steenbrugge GJ; Trapman J Cancer Res; 1998 Jul; 58(13):2720-3. PubMed ID: 9661880 [TBL] [Abstract][Full Text] [Related]
9. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. Okami K; Wu L; Riggins G; Cairns P; Goggins M; Evron E; Halachmi N; Ahrendt SA; Reed AL; Hilgers W; Kern SE; Koch WM; Sidransky D; Jen J Cancer Res; 1998 Feb; 58(3):509-11. PubMed ID: 9458098 [TBL] [Abstract][Full Text] [Related]
10. PTEN/MMAC1 expression in esophageal squamous cell carcinomas. Ding Y; Shimada Y; Kano M; Itami A; Kawabe A; Maeda M; Li Z; Hong T; Sato F; Kaganoi J; Imamura M Int J Oncol; 2000 Oct; 17(4):695-9. PubMed ID: 10995879 [TBL] [Abstract][Full Text] [Related]
11. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Wu X; Senechal K; Neshat MS; Whang YE; Sawyers CL Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15587-91. PubMed ID: 9861013 [TBL] [Abstract][Full Text] [Related]
12. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Liu W; James CD; Frederick L; Alderete BE; Jenkins RB Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744 [TBL] [Abstract][Full Text] [Related]
13. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402 [TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913 [TBL] [Abstract][Full Text] [Related]
15. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis. Hosoya Y; Gemma A; Seike M; Kurimoto F; Uematsu K; Hibino S; Yoshimura A; Shibuya M; Kudoh S Lung Cancer; 1999 Aug; 25(2):87-93. PubMed ID: 10470842 [TBL] [Abstract][Full Text] [Related]
16. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Steck PA; Pershouse MA; Jasser SA; Yung WK; Lin H; Ligon AH; Langford LA; Baumgard ML; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng DH; Tavtigian SV Nat Genet; 1997 Apr; 15(4):356-62. PubMed ID: 9090379 [TBL] [Abstract][Full Text] [Related]
17. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers. Yaginuma Y; Yamashita T; Ishiya T; Morizaki A; Katoh Y; Takahashi T; Hayashi H; Ishikawa M Mol Carcinog; 2000 Feb; 27(2):110-6. PubMed ID: 10657903 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers. Kohno T; Takahashi M; Manda R; Yokota J Genes Chromosomes Cancer; 1998 Jun; 22(2):152-6. PubMed ID: 9598803 [TBL] [Abstract][Full Text] [Related]
19. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles. Kurose K; Bando K; Fukino K; Sugisaki Y; Araki T; Emi M Jpn J Cancer Res; 1998 Aug; 89(8):842-8. PubMed ID: 9765621 [TBL] [Abstract][Full Text] [Related]
20. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Yokomizo A; Tindall DJ; Drabkin H; Gemmill R; Franklin W; Yang P; Sugio K; Smith DI; Liu W Oncogene; 1998 Jul; 17(4):475-9. PubMed ID: 9696041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]